Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3355899
Max Phase: Preclinical
Molecular Formula: C45H54O22
Molecular Weight: 946.90
Molecule Type: Small molecule
Associated Items:
ID: ALA3355899
Max Phase: Preclinical
Molecular Formula: C45H54O22
Molecular Weight: 946.90
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCC(=O)O[C@@H]1[C@@H](OC(=O)CC)[C@H](C)O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](OC(=O)CC)[C@@H](OC(=O)CC)[C@@H]2OC(=O)CC)[C@@H]1OC(=O)CC
Standard InChI: InChI=1S/C45H54O22/c1-8-28(50)61-36-20(7)58-44(42(65-32(54)12-5)40(36)63-30(52)10-3)57-19-27-38(62-29(51)9-2)41(64-31(53)11-4)43(66-33(55)13-6)45(60-27)67-39-35(56)34-25(49)17-22(46)18-26(34)59-37(39)21-14-15-23(47)24(48)16-21/h14-18,20,27,36,38,40-49H,8-13,19H2,1-7H3/t20-,27+,36-,38+,40+,41-,42+,43+,44+,45-/m0/s1
Standard InChI Key: LTZZHKSZCIKPEB-WYJDXCLYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 946.90 | Molecular Weight (Monoisotopic): 946.3107 | AlogP: 4.08 | #Rotatable Bonds: 18 |
Polar Surface Area: 305.85 | Molecular Species: ACID | HBA: 22 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 22 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 6.37 | CX Basic pKa: | CX LogP: 5.98 | CX LogD: 4.83 |
Aromatic Rings: 3 | Heavy Atoms: 67 | QED Weighted: 0.08 | Np Likeness Score: 1.28 |
1. Baldisserotto A, Vertuani S, Bino A, De Lucia D, Lampronti I, Milani R, Gambari R, Manfredini S.. (2015) Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties., 23 (1): [PMID:25496805] [10.1016/j.bmc.2014.10.023] |
Source(1):